SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
迷人紫萱
Lv0
0 积分
2023-12-12 加入
最近求助
最近应助
互助留言
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing
12天前
已完结
CNS Antitumor Activity of Amivantamab With Osimertinib in Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer With Acquired Mesenchymal-Epithelial Transition Amplification Resistance Mechanism: A Case Report
12天前
已完结
The PARTNER trial of neoadjuvant olaparib in triple-negative breast cancer
20天前
已完结
中国髓母细胞瘤整合诊治指南
3个月前
已完结
肝癌新辅助治疗中国专家共识(2023版)
3个月前
已完结
肝癌新辅助治疗中国专家共识(2023版)
3个月前
已关闭
Near-Complete Pathological Response to Abemaciclib in the Treatment of Well-Differentiated/Dedifferentiated Liposarcoma: A Case Report. Near-Complete Pathological Response to Abemaciclib in the Treatment of Well-Differentiated/Dedifferentiated Liposarcoma: A Case Report
4个月前
已完结
EML4-ALK Variant 3a/b as a mechanism of osimertinib resistance in a patient with EGFR L858R positive NSCLC
4个月前
已完结
没有进行任何应助
不是求助的文献
10天前
速度真快
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论